𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum steroids in relation to prostate cancer risk in a case-control study (Greece)

✍ Scribed by Lisa B. Signorello; Anastasia Tzonou; Christos S. Mantzoros; Loren Lipworth; Pagona Lagiou; Chung-cheng Hsieh; Meir Stampfer; Dimitrios Trichopoulos

Book ID
110370454
Publisher
Springer Netherlands
Year
1997
Tongue
English
Weight
48 KB
Volume
8
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk factors for prostate cancer: a case
Risk factors for prostate cancer: a case-control study in Greece
✍ C.-c. Hsieh; A. Thanos; D. Mitropoulos; Ch. Deliveliotis; C.S. Mantzoros; D. Tri πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 47 KB πŸ‘ 3 views

A case-control study of prostate cancer (PC) was undertaken in Athens, Greece. Cases were 320 patients with histologically confirmed incident disease, whereas controls were 246 patients without history or symptomatology of benign prostatic hyperplasia, treated in the same hospitals as the cases for

Serum estrogen levels and prostate cance
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study
✍ Song Yao; Cathee Till; Alan R. Kristal; Phyllis J. Goodman; Ann W. Hsing; Cather πŸ“‚ Article πŸ“… 2011 πŸ› Springer Netherlands 🌐 English βš– 190 KB

## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con

Diet and cancer of the prostate: a case-
Diet and cancer of the prostate: a case-control study in Greece
✍ A. Tzonou; L.B. Signorello; P. Lagiou; J. Wuu; D. Trichopoulos; A. Trichopoulou πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 49 KB πŸ‘ 3 views

The nutritional aetiology of prostate cancer was evaluated in Athens, Greece, through a case-control study that included 320 patients with histologically confirmed incident prostate cancer and 246 controls without history or symptomatology of benign prostatic hyperplasia or prostate cancer, treated